A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

BACKGROUND: Concurrent treatment with temozolomide and radiotherapy followed by maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor A, is currently approved for recurr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gilbert, Mark R., Dignam, James J., Armstrong, Terri S., Wefel, Jeffrey S., Blumenthal, Deborah T., Vogelbaum, Michael A., Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D., Jaeckle, Kurt A., Schiff, David, Stieber, Volker W., Brachman, David G., Werner-Wasik, Maria, Tremont-Lukats, Ivo W., Sulman, Erik P., Aldape, Kenneth D., Curran, Walter J., Mehta, Minesh P.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201043/
https://ncbi.nlm.nih.gov/pubmed/24552317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1308573
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky